Rchr
J-GLOBAL ID：201401085806738216   Update date: Sep. 20, 2024

Atsushi Yonezawa

ヨネザワ アツシ | Atsushi Yonezawa
Affiliation and department：
Kyoto University Graduate School of Pharmaceutical Sciences

About Kyoto University Graduate School of Pharmaceutical Sciences


Other affiliations (1)：
Homepage URL  (1)： http://kaken.nii.ac.jp/d/r/90452341.ja.html
Research field  (2)： Clinical pharmacy ,  Pharmacology
Research keywords  (21)： Pharmacokinetics, Pharmacology, Toxicology ,  薬学 ,  シスプラチン ,  トランスポータ ,  毒性学 ,  腎臓 ,  マイクロアレイ ,  先天性疾患 ,  ビタミンB2 ,  膜タンパク質 ,  薬物生態学 ,  医療薬剤学 ,  薬物動態学 ,  メタボリックシンドローム ,  核内受容体 ,  薬剤反応 ,  メトホルミン ,  薬物体内動態 ,  転写因子 ,  副作用 ,  薬物トランスポータ
Research theme for competitive and other funds  (11)：
  • 2023 - 2027 Analysis of biotransformation in therapeutic antibody
  • 2019 - 2023 Basic and clinical analysis of anti-drug antibody against therapeutic antibody
  • 2015 - 2018 Phathological analysis of RFVT knockout mice
  • 2012 - 2015 Pathophysiology of riboflavin transporter deficiency for developing therapeutic drugs
  • 2012 - 2015 Individualized L-dopa therapy in patients with Parkinson's disease
Show all
Papers (160)：
  • Mari Yokoi, Atsushi Yonezawa, Daiki Hira, Tomohiro Handa, Kiminobu Tanizawa, Shunsaku Nakagawa, Masahiro Tsuda, Yasuaki Ikemi, Ryo Itotani, Hironori Yoshida, et al. Subjective symptoms are triggers for the detection of immune checkpoint inhibitor-induced interstitial lung disease and associate with disease severity: a single-center retrospective study. Journal of Pharmaceutical Health Care and Sciences. 2024. 10. 1
  • Mitsuhiro Sugimoto, Atsushi Yonezawa, Junya Kanda, Kotaro Itohara, Daiki Hira, Takeo Yamagiwa, Risa Taniguchi, Yuta Hanyu, Mizuki Watanabe, Yasuyuki Arai, et al. Population Pharmacokinetic Modeling of Posaconazole in Japanese Patients Receiving Fungal Prophylaxis. Therapeutic drug monitoring. 2024
  • Masayoshi Kawata, Atsushi Yonezawa, Yohei Mineharu, Kotaro Itohara, Toshiyuki Mizota, Yoshihiro Matsui, Takayuki Kikuchi, Yukihiro Yamao, Etsuko Yamamoto Hattori, Miho Hamada, et al. Development of extended pharmacokinetic models for propofol based on measured blood and brain concentrations. Scientific reports. 2024. 14. 1. 6326-6326
  • Takashi Masuda, Taro Funakoshi, Takahiro Horimatsu, Shinya Yamamoto, Takeshi Matsubara, Sho Masui, Shunsaku Nakagawa, Yasuaki Ikemi, Motoko Yanagita, Manabu Muto, et al. Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria: a case series. Cancer chemotherapy and pharmacology. 2024
  • Tomoya Kawakami, Sho Masui, Akira Onishi, Hideo Onizawa, Takayuki Fujii, Kosaku Murakami, Koichi Murata, Masao Tanaka, Takashi Shimada, Shunsaku Nakagawa, et al. Comparison of safety and effectiveness between etanercept biosimilar LBEC0101 and reference in patients with rheumatoid arthritis in real-world data using the KURAMA cohort. Modern rheumatology. 2024
ｍore...
MISC (215)：
ｍore...
Professional career (1)：
  • 博士(薬) (京都大学)
Work history (3)：
  • 2013/06/01 - Kyoto University Hospital Senior Lecturer
  • 2007 - 2012 Kyoto University
  • 2007/04/01 - Kyoto University Hospital Assistant Professor
Association Membership(s) (5)：
Japanese Society of Clinical Pharmacology and Therapeutics ,  Academy of Pharmaceutical Science and Technology, Japan ,  Japanese Society for the Study of Xenobiotics ,  Pharmaceutical Society of Japan ,  Japanese Society of Pharmaceutical Health Care and Sciences
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM